Patents for A61P 17 - Drugs for dermatological disorders (106,455)
07/1997
07/30/1997EP0785784A1 4-heterocyclic piperidines promote release of growth hormone
07/30/1997EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
07/30/1997EP0785715A1 Method for delipidation of skin and cerumen removal
07/30/1997CN1155838A Indolinone compounds for the treatment of disease
07/30/1997CN1155429A Medicine for acne and its preparation
07/30/1997CN1155418A Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity
07/29/1997US5652273 Reduction of hair growth
07/29/1997US5652266 Skin improvement, a-hydroxy acid, salicylic acid or ester, and retinoid
07/29/1997US5652252 Potassium channel activators
07/29/1997US5652243 Modulating cellular response
07/29/1997US5652230 Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy
07/29/1997US5652229 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
07/29/1997US5652228 Salicylic acid and zwitterionic surfactant, treatment of acne, skin conditioners, removing surface scales
07/29/1997US5652227 Inhibition of the degradation of connective tissue matrix protein components in mammals
07/29/1997US5652217 Nucleotide sequence from staphylococcus aureus which codes for protein or polypeptide
07/29/1997US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM
07/29/1997US5651993 Irradiating leukocyte mixture in psoralen presence; reacting with peptide antigens
07/29/1997US5651982 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
07/29/1997CA1339085C Cosmetic and pharmaceutical compositions containing benzoyl peroxide andquaternary ammonium salts thereof
07/24/1997WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE
07/24/1997WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026265A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
07/24/1997WO1997026264A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
07/24/1997WO1997025998A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same
07/24/1997WO1997025977A1 Pharmaceutical compositions
07/24/1997WO1997025969A1 Method of inhibiting photoaging of skin
07/24/1997DE19602208A1 In-situ gebildete Arzneiform zur Abgabe von Enzymen an Wunden In-situ formed dosage form for delivering enzymes to wounds
07/24/1997DE19602110A1 Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Zusammensetzungen auf der Basis von Squalen und Sphingolipiden Against bacteria, parasites, protozoa, and viruses mycota effective compositions based on squalene and sphingolipids
07/24/1997CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives
07/24/1997CA2241567A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
07/24/1997CA2241565A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
07/24/1997CA2216600A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same
07/23/1997EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus
07/23/1997EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus
07/23/1997EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus
07/23/1997EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase
07/23/1997EP0784980A1 Collagen hydrolysis accelerator
07/23/1997EP0784975A1 Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
07/23/1997EP0784682A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
07/23/1997EP0784677A1 Inhibitor of stem cell proliferation and uses thereof
07/23/1997EP0784624A1 Purine and guanine compounds as inhibitors of pnp
07/23/1997EP0784613A1 Colchicine derivatives and the therapeutical use thereof
07/23/1997EP0784430A1 Method for reducing unwanted cellular adhesions
07/23/1997EP0540717B1 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS
07/23/1997CN1155245A Use of muramyl peptide compounds
07/23/1997CN1154856A Natural freckle-diminishing face-beautifying product and peparation method thereof
07/22/1997US5650494 Process for refolding recombinantly produced TGF-β-like proteins
07/22/1997US5650445 3,4-diphenyl-3-hexene
07/22/1997US5650166 Lipid vesicles for skin treatment
07/22/1997US5650158 Moisture-regulating composition for cosmetics or dermatology
07/22/1997US5650145 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith
07/22/1997US5650137 Cosmetic composition containing a superoxide dismutase and a porphyrin
07/22/1997CA2020923C Urethane derivative, their preparation and their applications as hydrating agents in cosmetic or pharmaceutical compositions for the treatment of dry skin
07/17/1997WO1997025425A1 Wsx receptor and ligands
07/17/1997WO1997025404A1 Disinfecting compositions and processes for disinfecting surfaces
07/17/1997WO1997025352A1 PROCESS FOR ISOLATING IgG AND IgA
07/17/1997WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
07/17/1997WO1997025106A1 Disinfecting compositions and processes for disinfecting surfaces
07/17/1997WO1997025059A1 Using serine-proteases for acne and inflamed comedones
07/17/1997WO1997025048A1 Novel cycloalkyl substituted imidazoles
07/17/1997WO1997025047A1 Novel cycloalkyl substituded imidazoles
07/17/1997WO1997025046A1 Novel substituted imidazole compounds
07/17/1997WO1997025045A1 Novel substituted imidazole compounds
07/17/1997WO1997025036A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
07/17/1997WO1997025022A1 Skin care composition
07/17/1997WO1997025020A1 Cosmetic and dermatological sunscreen formulations containing triazine derivatives and alkane carboxylic acids
07/17/1997DE19601104A1 Kosmetische und dermatologische Lichtschutzzubereitungen mit einem Gehalt an Triazinderivaten und Alkancarbonsäuren Cosmetic and dermatological light protection preparations containing triazine derivatives and alkane carboxylic acids
07/17/1997CA2242778A1 Process for isolating igg and iga
07/17/1997CA2242411A1 Disinfecting compositions and processes for disinfecting surfaces
07/17/1997CA2242391A1 Disinfecting compositions and processes for disinfecting surfaces
07/17/1997CA2242348A1 Skin care composition
07/17/1997CA2242327A1 Novel substituted imidazole compounds
07/17/1997CA2241564A1 Wsx receptor and ligands
07/17/1997CA2241556A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
07/16/1997EP0783890A1 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine for the treatment of fungal dermatitis
07/16/1997EP0783887A2 Topical compositions for the treatment of hyperproliferative skin disease
07/16/1997EP0783507A1 Compounds useful as antiproliferative agents and garft inhibitors
07/16/1997EP0783505A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE
07/16/1997EP0783488A1 Five membered heterocyclic compounds
07/16/1997EP0783307A1 Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders
07/16/1997EP0783303A1 Use of aromatic halides for treating mammalian cell proliferation
07/16/1997EP0681558B1 Stable sulfide compositions, uses, and process for preparation thereof
07/16/1997CN1154705A Organic compound
07/16/1997CN1154652A Desquamation compositions
07/16/1997CN1154365A Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products
07/16/1997CN1154250A Hair-growth, beauty-care and health-care medicinal liquor, and method for preparing same
07/16/1997CN1154245A Turtle oil, soft-shelled turtle oil and compositions contg. same, and the use thereof
07/15/1997US5648585 Process for isomerizing linear olefins to isoolefins